Pfizer Korea will co-market 2 blockbuster autoimmune disease drugs with a local drug distributor Hanlim MS. Pfizer has signed copromotion deals with Jeil Pharmaceutical, Donghwa Pharm, and Chong Ku Dang, but this is the first time the company has signed a co-marketing partnership deal with Hanlim MS. The company explained that it decided to partner with Hanlim MS because it owns various capabilities in distribution and supply in the field of autoimmune disease treatment.

According to industry sources on the 3rd, Pfizer announced that it will co-market its autoimmune disease drug Enbrel with Hanlim MS. This is the second agreement the companies have made, following the co-marketing agreement of Janus k